A Controlled Trial of Ambroxol in Chronic...

A Controlled Trial of Ambroxol in Chronic Bronchitis

Abstract

Ambroxol is a mucolytic agent which is widely used in chronic bronchitis in Europe. We conducted a double-blind randomized controlled trial of ambroxol vs matched placebo in 90 patients with chronic bronchitis and difficulty clearing secretions. It was concluded that there was no advantage to taking ambroxol.

Authors

Guyatt GH; Townsend M; Kazim F; Newhouse MT

Journal

Chest, Vol. 92, No. 4, pp. 618–620

Publisher

Elsevier

Publication Date

October 1, 1987

DOI

10.1378/chest.92.4.618

ISSN

0012-3692

Associated Experts

Gordon Guyatt

Professor, Faculty of Health Sciences

Visit profile

Labels